BidaskClub downgraded shares of Intuitive Surgical (NASDAQ:ISRG) from a strong-buy rating to a buy rating in a research note released on Saturday morning.

Other equities research analysts have also issued research reports about the stock. Zacks Investment Research raised shares of Intuitive Surgical from a hold rating to a buy rating and set a $409.00 price target on the stock in a report on Wednesday, January 3rd. Wells Fargo & Co reissued a buy rating on shares of Intuitive Surgical in a report on Monday, October 16th. Goldman Sachs Group reissued a buy rating on shares of Intuitive Surgical in a report on Saturday, November 18th. Vetr raised shares of Intuitive Surgical from a hold rating to a buy rating and set a $434.75 price target on the stock in a report on Monday, January 8th. Finally, Stifel Nicolaus reissued a buy rating and issued a $480.00 price target (up previously from $400.00) on shares of Intuitive Surgical in a report on Thursday, January 25th. One equities research analyst has rated the stock with a sell rating, six have assigned a hold rating, thirteen have issued a buy rating and one has issued a strong buy rating to the stock. Intuitive Surgical has a consensus rating of Buy and a consensus target price of $408.48.

Shares of Intuitive Surgical (NASDAQ:ISRG) opened at $402.00 on Friday. The stock has a market cap of $45,040.00, a price-to-earnings ratio of 70.77, a price-to-earnings-growth ratio of 4.63 and a beta of 0.50. Intuitive Surgical has a twelve month low of $236.75 and a twelve month high of $452.00.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings results on Thursday, January 25th. The medical equipment provider reported $2.54 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.27 by $0.27. The business had revenue of $892.40 million for the quarter, compared to analyst estimates of $866.54 million. Intuitive Surgical had a net margin of 21.09% and a return on equity of 19.93%. The company’s revenue was up 17.9% on a year-over-year basis. During the same quarter last year, the firm earned $2.03 EPS. equities analysts anticipate that Intuitive Surgical will post 7.93 earnings per share for the current year.

In related news, SVP Mark J. Meltzer sold 6,000 shares of Intuitive Surgical stock in a transaction dated Tuesday, November 21st. The shares were sold at an average price of $397.14, for a total transaction of $2,382,840.00. Following the completion of the transaction, the senior vice president now directly owns 9,888 shares of the company’s stock, valued at approximately $3,926,920.32. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. Also, CEO Gary S. Guthart sold 7,724 shares of Intuitive Surgical stock in a transaction dated Wednesday, February 7th. The shares were sold at an average price of $414.50, for a total transaction of $3,201,598.00. Following the transaction, the chief executive officer now directly owns 275,220 shares of the company’s stock, valued at $114,078,690. The disclosure for this sale can be found here. Over the last three months, insiders have sold 85,016 shares of company stock valued at $35,133,026. 2.20% of the stock is currently owned by corporate insiders.

Hedge funds and other institutional investors have recently modified their holdings of the stock. Lincoln National Corp purchased a new position in Intuitive Surgical during the 3rd quarter valued at about $200,000. MUFG Americas Holdings Corp purchased a new position in Intuitive Surgical in the third quarter worth about $208,000. Advisors Capital Management LLC purchased a new position in Intuitive Surgical in the third quarter worth about $209,000. Capital Investment Counsel Inc purchased a new position in Intuitive Surgical in the third quarter worth about $209,000. Finally, Coldstream Capital Management Inc. purchased a new position in Intuitive Surgical in the third quarter worth about $214,000. 36.79% of the stock is owned by institutional investors.

COPYRIGHT VIOLATION WARNING: “Intuitive Surgical (ISRG) Downgraded by BidaskClub to Buy” was posted by The Cerbat Gem and is owned by of The Cerbat Gem. If you are viewing this report on another site, it was illegally copied and republished in violation of United States and international copyright & trademark legislation. The correct version of this report can be read at https://www.thecerbatgem.com/2018/02/14/intuitive-surgical-isrg-downgraded-by-bidaskclub-to-buy.html.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc (Intuitive) designs, manufactures and markets da Vinci Surgical Systems, and related instruments and accessories. The Company’s da Vinci Surgical System consists of a surgeon’s console, a patient-side cart and a vision system. The da Vinci Surgical System translates a surgeon’s hand movements, which are performed on instrument controls at a console, into corresponding micro-movements of instruments positioned inside the patient through small incisions or ports.

Analyst Recommendations for Intuitive Surgical (NASDAQ:ISRG)

Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.